""	"curation_date"	"cohort"	"age_min"	"age_max"	"age_units"	"number_subjects"	"tissue_type"	"response_component_original"	"is_model"	"response_behavior_type"	"response_behavior"	"comparison"	"baseline_time_event"	"time_point"	"time_point_units"	"exposure_material_id"	"additional_exposure_material"	"target_pathogen"	"vaccine_year"	"adjuvant"	"route"	"scheduling"	"publication_reference_id"	"publication_reference_url"	"publication_year"	"signature_source"	"signature_source_url"	"comments"	"response_component"	"submission_name"	"submission_date"	"template_name"	"response_comp_orig_cnt"	"response_comp_cnt"	"subm_obs_id"	"uniq_obs_id"	"row_key"	"signature_file"	"signature_file_complete"
"subject"	""	""	""	""	""	""	"cell_subset"	""	""	""	""	""	""	""	""	"vaccine"	""	"pathogen"	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"evidence"	"label"	"label"	"label"	"label"	"label"	"label"	""	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	""	"label"	""	"label"	"label"	"label"	"label"	"label"	"url"	"label"	"label"	"label"	"label"	""	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"file"	"file"
"role"	"background"	"observed"	"observed"	"observed"	"observed"	"observed"	"tissue"	"observed"	"background"	"background"	"measured"	"background"	"background"	"observed"	"observed"	"vaccine"	"background"	"pathogen"	"background"	"background"	"background"	"background"	"background"	"reference"	"background"	"background"	"background"	"background"	""	"background"	"background"	"background"	"observed"	"observed"	"background"	"background"	"background"	"observed"	"observed"
"mime_type"	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"numeric_units"	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"display_text"	"curation date"	"cohort"	"age min."	"age max."	"age units"	"number of subjects"	"tissue type"	"response component (original gene symbol)"	"gene signature is a computed model"	"response behavior type"	"response behavior"	"comparison"	"baseline time"	"time point"	"time point units"	"exposure material (VO)"	"exposure material - additional"	"target pathogen"	"vaccine year (influenza only)"	"adjuvant"	"route"	"scheduling"	"publication reference (PMID)"	"Erwin-Cohen et al. (2012) Host responses to live-attenuated Venezuelan equine encephalitis virus (TC-83): comparison of na√Øve, vaccine responder and nonresponder to TC-83 challenge in human peripheral blood mononuclear cells. Hum Vaccin Immunother. PMID: <a href = 'https://www.ncbi.nlm.nih.gov/pubmed/?term=22617845' target='_blank'>22617845</a>"	"print publication year"	"signature source figure, table or text section"	"signature source url"	"comments and additional details"	""	"submission name"	"submission_date"	"template_name"	"response component (original) count"	"response component count"	"ID of observation within its own submission"	"Uniq ID of observation within its submission type"	"row key"	"response component (genes) file"	" response components including non-HGNC genes"
""	""	"adults (18-45), subgroup non-responders (previously immunized)"	"18"	"45"	"years"	""	"peripheral blood mononuclear cell"	"C5AR1"	"N"	"gene expression"	"down-regulated"	"24h vs 0h"	"time of challenge infection (PBMCs, in vitro)"	"24"	"hours"	"VO_0004105"	"Live attenuated vaccine TC-83 challenge"	"venezuelan equine encephalitis virus (strain TC-83)"	""	""	""	""	"22617845"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=22617845"	"2012"	"Table 3"	"<a href = 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551876/table/T3/' target='_blank'>table/T3</a>"	"initial exposure 2-10 months before PBMCs drawn. significant genes chosen for membership in canonical pathways"	"C5AR1"	"hipc_gene_22617845_8"	"2012.05.24"	"hipc_gene_22617845_8"	"19"	"15"	"8"	"112"	"22617845_8_112"	"hipc_gene_sig_22617845_8.txt"	"hipc_gene_sig_complete_22617845_8.txt"
""	""	"adults (18-45), subgroup non-responders (previously immunized)"	"18"	"45"	"years"	""	"peripheral blood mononuclear cell"	"TLR4"	"N"	"gene expression"	"down-regulated"	"24h vs 0h"	"time of challenge infection (PBMCs, in vitro)"	"24"	"hours"	"VO_0004105"	"Live attenuated vaccine TC-83 challenge"	"venezuelan equine encephalitis virus (strain TC-83)"	""	""	""	""	"22617845"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=22617845"	"2012"	"Table 3"	"<a href = 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551876/table/T3/' target='_blank'>table/T3</a>"	"initial exposure 2-10 months before PBMCs drawn. significant genes chosen for membership in canonical pathways"	"TLR4"	"hipc_gene_22617845_8"	"2012.05.24"	"hipc_gene_22617845_8"	"19"	"15"	"8"	"112"	"22617845_8_112"	"hipc_gene_sig_22617845_8.txt"	"hipc_gene_sig_complete_22617845_8.txt"
""	""	"adults (18-45), subgroup non-responders (previously immunized)"	"18"	"45"	"years"	""	"peripheral blood mononuclear cell"	"TLR8"	"N"	"gene expression"	"down-regulated"	"24h vs 0h"	"time of challenge infection (PBMCs, in vitro)"	"24"	"hours"	"VO_0004105"	"Live attenuated vaccine TC-83 challenge"	"venezuelan equine encephalitis virus (strain TC-83)"	""	""	""	""	"22617845"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=22617845"	"2012"	"Table 3"	"<a href = 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551876/table/T3/' target='_blank'>table/T3</a>"	"initial exposure 2-10 months before PBMCs drawn. significant genes chosen for membership in canonical pathways"	"TLR8"	"hipc_gene_22617845_8"	"2012.05.24"	"hipc_gene_22617845_8"	"19"	"15"	"8"	"112"	"22617845_8_112"	"hipc_gene_sig_22617845_8.txt"	"hipc_gene_sig_complete_22617845_8.txt"
""	""	"adults (18-45), subgroup non-responders (previously immunized)"	"18"	"45"	"years"	""	"peripheral blood mononuclear cell"	"NLRC4"	"N"	"gene expression"	"down-regulated"	"24h vs 0h"	"time of challenge infection (PBMCs, in vitro)"	"24"	"hours"	"VO_0004105"	"Live attenuated vaccine TC-83 challenge"	"venezuelan equine encephalitis virus (strain TC-83)"	""	""	""	""	"22617845"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=22617845"	"2012"	"Table 3"	"<a href = 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551876/table/T3/' target='_blank'>table/T3</a>"	"initial exposure 2-10 months before PBMCs drawn. significant genes chosen for membership in canonical pathways"	"NLRC4"	"hipc_gene_22617845_8"	"2012.05.24"	"hipc_gene_22617845_8"	"19"	"15"	"8"	"112"	"22617845_8_112"	"hipc_gene_sig_22617845_8.txt"	"hipc_gene_sig_complete_22617845_8.txt"
""	""	"adults (18-45), subgroup non-responders (previously immunized)"	"18"	"45"	"years"	""	"peripheral blood mononuclear cell"	"CLEC7A"	"N"	"gene expression"	"down-regulated"	"24h vs 0h"	"time of challenge infection (PBMCs, in vitro)"	"24"	"hours"	"VO_0004105"	"Live attenuated vaccine TC-83 challenge"	"venezuelan equine encephalitis virus (strain TC-83)"	""	""	""	""	"22617845"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=22617845"	"2012"	"Table 3"	"<a href = 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551876/table/T3/' target='_blank'>table/T3</a>"	"initial exposure 2-10 months before PBMCs drawn. significant genes chosen for membership in canonical pathways"	"CLEC7A"	"hipc_gene_22617845_8"	"2012.05.24"	"hipc_gene_22617845_8"	"19"	"15"	"8"	"112"	"22617845_8_112"	"hipc_gene_sig_22617845_8.txt"	"hipc_gene_sig_complete_22617845_8.txt"
""	""	"adults (18-45), subgroup non-responders (previously immunized)"	"18"	"45"	"years"	""	"peripheral blood mononuclear cell"	"C1QA"	"N"	"gene expression"	"down-regulated"	"24h vs 0h"	"time of challenge infection (PBMCs, in vitro)"	"24"	"hours"	"VO_0004105"	"Live attenuated vaccine TC-83 challenge"	"venezuelan equine encephalitis virus (strain TC-83)"	""	""	""	""	"22617845"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=22617845"	"2012"	"Table 3"	"<a href = 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551876/table/T3/' target='_blank'>table/T3</a>"	"initial exposure 2-10 months before PBMCs drawn. significant genes chosen for membership in canonical pathways"	"C1QA"	"hipc_gene_22617845_8"	"2012.05.24"	"hipc_gene_22617845_8"	"19"	"15"	"8"	"112"	"22617845_8_112"	"hipc_gene_sig_22617845_8.txt"	"hipc_gene_sig_complete_22617845_8.txt"
""	""	"adults (18-45), subgroup non-responders (previously immunized)"	"18"	"45"	"years"	""	"peripheral blood mononuclear cell"	"C1QB"	"N"	"gene expression"	"down-regulated"	"24h vs 0h"	"time of challenge infection (PBMCs, in vitro)"	"24"	"hours"	"VO_0004105"	"Live attenuated vaccine TC-83 challenge"	"venezuelan equine encephalitis virus (strain TC-83)"	""	""	""	""	"22617845"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=22617845"	"2012"	"Table 3"	"<a href = 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551876/table/T3/' target='_blank'>table/T3</a>"	"initial exposure 2-10 months before PBMCs drawn. significant genes chosen for membership in canonical pathways"	"C1QB"	"hipc_gene_22617845_8"	"2012.05.24"	"hipc_gene_22617845_8"	"19"	"15"	"8"	"112"	"22617845_8_112"	"hipc_gene_sig_22617845_8.txt"	"hipc_gene_sig_complete_22617845_8.txt"
""	""	"adults (18-45), subgroup non-responders (previously immunized)"	"18"	"45"	"years"	""	"peripheral blood mononuclear cell"	"FOS"	"N"	"gene expression"	"down-regulated"	"24h vs 0h"	"time of challenge infection (PBMCs, in vitro)"	"24"	"hours"	"VO_0004105"	"Live attenuated vaccine TC-83 challenge"	"venezuelan equine encephalitis virus (strain TC-83)"	""	""	""	""	"22617845"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=22617845"	"2012"	"Table 3"	"<a href = 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551876/table/T3/' target='_blank'>table/T3</a>"	"initial exposure 2-10 months before PBMCs drawn. significant genes chosen for membership in canonical pathways"	"FOS"	"hipc_gene_22617845_8"	"2012.05.24"	"hipc_gene_22617845_8"	"19"	"15"	"8"	"112"	"22617845_8_112"	"hipc_gene_sig_22617845_8.txt"	"hipc_gene_sig_complete_22617845_8.txt"
""	""	"adults (18-45), subgroup non-responders (previously immunized)"	"18"	"45"	"years"	""	"peripheral blood mononuclear cell"	"CEBPB"	"N"	"gene expression"	"down-regulated"	"24h vs 0h"	"time of challenge infection (PBMCs, in vitro)"	"24"	"hours"	"VO_0004105"	"Live attenuated vaccine TC-83 challenge"	"venezuelan equine encephalitis virus (strain TC-83)"	""	""	""	""	"22617845"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=22617845"	"2012"	"Table 3"	"<a href = 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551876/table/T3/' target='_blank'>table/T3</a>"	"initial exposure 2-10 months before PBMCs drawn. significant genes chosen for membership in canonical pathways"	"CEBPB"	"hipc_gene_22617845_8"	"2012.05.24"	"hipc_gene_22617845_8"	"19"	"15"	"8"	"112"	"22617845_8_112"	"hipc_gene_sig_22617845_8.txt"	"hipc_gene_sig_complete_22617845_8.txt"
""	""	"adults (18-45), subgroup non-responders (previously immunized)"	"18"	"45"	"years"	""	"peripheral blood mononuclear cell"	"RXRA"	"N"	"gene expression"	"down-regulated"	"24h vs 0h"	"time of challenge infection (PBMCs, in vitro)"	"24"	"hours"	"VO_0004105"	"Live attenuated vaccine TC-83 challenge"	"venezuelan equine encephalitis virus (strain TC-83)"	""	""	""	""	"22617845"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=22617845"	"2012"	"Table 3"	"<a href = 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551876/table/T3/' target='_blank'>table/T3</a>"	"initial exposure 2-10 months before PBMCs drawn. significant genes chosen for membership in canonical pathways"	"RXRA"	"hipc_gene_22617845_8"	"2012.05.24"	"hipc_gene_22617845_8"	"19"	"15"	"8"	"112"	"22617845_8_112"	"hipc_gene_sig_22617845_8.txt"	"hipc_gene_sig_complete_22617845_8.txt"
""	""	"adults (18-45), subgroup non-responders (previously immunized)"	"18"	"45"	"years"	""	"peripheral blood mononuclear cell"	"SPI1"	"N"	"gene expression"	"down-regulated"	"24h vs 0h"	"time of challenge infection (PBMCs, in vitro)"	"24"	"hours"	"VO_0004105"	"Live attenuated vaccine TC-83 challenge"	"venezuelan equine encephalitis virus (strain TC-83)"	""	""	""	""	"22617845"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=22617845"	"2012"	"Table 3"	"<a href = 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551876/table/T3/' target='_blank'>table/T3</a>"	"initial exposure 2-10 months before PBMCs drawn. significant genes chosen for membership in canonical pathways"	"SPI1"	"hipc_gene_22617845_8"	"2012.05.24"	"hipc_gene_22617845_8"	"19"	"15"	"8"	"112"	"22617845_8_112"	"hipc_gene_sig_22617845_8.txt"	"hipc_gene_sig_complete_22617845_8.txt"
""	""	"adults (18-45), subgroup non-responders (previously immunized)"	"18"	"45"	"years"	""	"peripheral blood mononuclear cell"	"CCL7"	"N"	"gene expression"	"down-regulated"	"24h vs 0h"	"time of challenge infection (PBMCs, in vitro)"	"24"	"hours"	"VO_0004105"	"Live attenuated vaccine TC-83 challenge"	"venezuelan equine encephalitis virus (strain TC-83)"	""	""	""	""	"22617845"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=22617845"	"2012"	"Table 3"	"<a href = 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551876/table/T3/' target='_blank'>table/T3</a>"	"initial exposure 2-10 months before PBMCs drawn. significant genes chosen for membership in canonical pathways"	"CCL7"	"hipc_gene_22617845_8"	"2012.05.24"	"hipc_gene_22617845_8"	"19"	"15"	"8"	"112"	"22617845_8_112"	"hipc_gene_sig_22617845_8.txt"	"hipc_gene_sig_complete_22617845_8.txt"
""	""	"adults (18-45), subgroup non-responders (previously immunized)"	"18"	"45"	"years"	""	"peripheral blood mononuclear cell"	"IL8"	"N"	"gene expression"	"down-regulated"	"24h vs 0h"	"time of challenge infection (PBMCs, in vitro)"	"24"	"hours"	"VO_0004105"	"Live attenuated vaccine TC-83 challenge"	"venezuelan equine encephalitis virus (strain TC-83)"	""	""	""	""	"22617845"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=22617845"	"2012"	"Table 3"	"<a href = 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551876/table/T3/' target='_blank'>table/T3</a>"	"initial exposure 2-10 months before PBMCs drawn. significant genes chosen for membership in canonical pathways"	"CXCL8"	"hipc_gene_22617845_8"	"2012.05.24"	"hipc_gene_22617845_8"	"19"	"15"	"8"	"112"	"22617845_8_112"	"hipc_gene_sig_22617845_8.txt"	"hipc_gene_sig_complete_22617845_8.txt"
""	""	"adults (18-45), subgroup non-responders (previously immunized)"	"18"	"45"	"years"	""	"peripheral blood mononuclear cell"	"TYROBP"	"N"	"gene expression"	"down-regulated"	"24h vs 0h"	"time of challenge infection (PBMCs, in vitro)"	"24"	"hours"	"VO_0004105"	"Live attenuated vaccine TC-83 challenge"	"venezuelan equine encephalitis virus (strain TC-83)"	""	""	""	""	"22617845"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=22617845"	"2012"	"Table 3"	"<a href = 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551876/table/T3/' target='_blank'>table/T3</a>"	"initial exposure 2-10 months before PBMCs drawn. significant genes chosen for membership in canonical pathways"	"TYROBP"	"hipc_gene_22617845_8"	"2012.05.24"	"hipc_gene_22617845_8"	"19"	"15"	"8"	"112"	"22617845_8_112"	"hipc_gene_sig_22617845_8.txt"	"hipc_gene_sig_complete_22617845_8.txt"
""	""	"adults (18-45), subgroup non-responders (previously immunized)"	"18"	"45"	"years"	""	"peripheral blood mononuclear cell"	"ITGAX"	"N"	"gene expression"	"down-regulated"	"24h vs 0h"	"time of challenge infection (PBMCs, in vitro)"	"24"	"hours"	"VO_0004105"	"Live attenuated vaccine TC-83 challenge"	"venezuelan equine encephalitis virus (strain TC-83)"	""	""	""	""	"22617845"	"https://www.ncbi.nlm.nih.gov/pubmed/?term=22617845"	"2012"	"Table 3"	"<a href = 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551876/table/T3/' target='_blank'>table/T3</a>"	"initial exposure 2-10 months before PBMCs drawn. significant genes chosen for membership in canonical pathways"	"ITGAX"	"hipc_gene_22617845_8"	"2012.05.24"	"hipc_gene_22617845_8"	"19"	"15"	"8"	"112"	"22617845_8_112"	"hipc_gene_sig_22617845_8.txt"	"hipc_gene_sig_complete_22617845_8.txt"
